New data to be presented at the 2025 american academy of dermatology (aad) annual meeting further strengthens evidence supporting the clinical value of castle biosciences' dermatology portfolio

Friendswood, texas--(business wire)---- $cstl #cstl--castle will share new data on its decisiondx-melanoma and decisiondx-scc tests for patients with skin cancers at the 2025 aad annual meeting.
CSTL Ratings Summary
CSTL Quant Ranking